-
1
-
-
0017317645
-
Polymers for the sustained release of proteins and other macromolecules
-
Langer, R. & Folkman, J. Polymers for the sustained release of proteins and other macromolecules. Nature 263, 797-800 (1976).
-
(1976)
Nature
, vol.263
, pp. 797-800
-
-
Langer, R.1
Folkman, J.2
-
2
-
-
14744306490
-
Biopharmaceutical R&D success rates and development times. A new analysis provides benchmarks for the future
-
Struck, M.M. Biopharmaceutical R&D success rates and development times. A new analysis provides benchmarks for the future. Bio/Technology 12, 674-677 (1994).
-
(1994)
Bio/Technology
, vol.12
, pp. 674-677
-
-
Struck, M.M.1
-
3
-
-
0027590742
-
The pharmaceutics and delivery of therapeutic polypeptides and proteins
-
Talmadge, J.E. The pharmaceutics and delivery of therapeutic polypeptides and proteins. Adv. Drug Delivery. Rev. 10, 247-299 (1993).
-
(1993)
Adv. Drug Delivery. Rev.
, vol.10
, pp. 247-299
-
-
Talmadge, J.E.1
-
4
-
-
0024337853
-
Controlled release of LHRH agonist, leuprolide acetate, from microcapsules: Serum drug level profiles and pharmacological effects in animals
-
Ogawa, Y., Okada, H., Heya, T. & Shimamota T. Controlled release of LHRH agonist, leuprolide acetate, from microcapsules: serum drug level profiles and pharmacological effects in animals. J. Pharm. Pharmcol. 41, 439-444 (1989).
-
(1989)
J. Pharm. Pharmcol.
, vol.41
, pp. 439-444
-
-
Ogawa, Y.1
Okada, H.2
Heya, T.3
Shimamota, T.4
-
5
-
-
0028029215
-
Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers
-
Okada, H., Doken, Y., Ogawa, Y. & Toguchi, H. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Pharm. Res. 11, 1143 (1994).
-
(1994)
Pharm. Res.
, vol.11
, pp. 1143
-
-
Okada, H.1
Doken, Y.2
Ogawa, Y.3
Toguchi, H.4
-
6
-
-
0027533485
-
Discovery and development of goserelin (Zoladex)
-
Dutta, A.S., Furr, B.J.A. & Hutchinson, F.G. Discovery and development of goserelin (Zoladex). Pharm. Med. 7, 9-28 (1993).
-
(1993)
Pharm. Med.
, vol.7
, pp. 9-28
-
-
Dutta, A.S.1
Furr, B.J.A.2
Hutchinson, F.G.3
-
7
-
-
0001930163
-
-
eds Cohen, S. & Bernstein, H., Marcel Dekker, New York
-
Schwendeman, S.P., Cardamone, M., Klibanov., A. & Langer, R. in Microparticulate systems for the delivery of proteins and vaccines (eds Cohen, S. & Bernstein, H.), 1-49 (Marcel Dekker, New York; 1996).
-
(1996)
Microparticulate Systems for the Delivery of Proteins and Vaccines
, pp. 1-49
-
-
Schwendeman, S.P.1
Cardamone, M.2
Klibanov, A.3
Langer, R.4
-
8
-
-
0000958535
-
-
ed. Park, K., American Chemical Society, Washington, D.C
-
Schwendeman, S.P., Costantino, H.R., Gupta, R.K. & Langer, R. in Controlled drug delivery, (ed. Park, K.), 229-267 (American Chemical Society, Washington, D.C; 1997).
-
(1997)
Controlled Drug Delivery,
, pp. 229-267
-
-
Schwendeman, S.P.1
Costantino, H.R.2
Gupta, R.K.3
Langer, R.4
-
9
-
-
15844364250
-
A month-long effect from a single injection of microencapsulated human growth hormone
-
Johnson, O.L. et al. A month-long effect from a single injection of microencapsulated human growth hormone. Nat. Med. 2, 795-799 (1996).
-
(1996)
Nat. Med.
, vol.2
, pp. 795-799
-
-
Johnson, O.L.1
-
10
-
-
0029859532
-
Stable formulations of recombinant human growth hormone and inlerferon-gamma for microencapsulation in biodegradable microspheres
-
Cleland, J.L. & Jones, A.J.S. Stable formulations of recombinant human growth hormone and inlerferon-gamma for microencapsulation in biodegradable microspheres. Pharm. Res. 13, 1464-1475 (1996).
-
(1996)
Pharm. Res.
, vol.13
, pp. 1464-1475
-
-
Cleland, J.L.1
Jones, A.J.S.2
-
11
-
-
0031941871
-
New strategies for the microencapsulation of tetanus vaccine
-
Schwendeman, S.P., Tobio, M., Joworowicz, M., Alonso, M.J. & Langer, R. New strategies for the microencapsulation of tetanus vaccine. J. Microencapsulation 15, 299-318 (1998).
-
(1998)
J. Microencapsulation
, vol.15
, pp. 299-318
-
-
Schwendeman, S.P.1
Tobio, M.2
Joworowicz, M.3
Alonso, M.J.4
Langer, R.5
-
12
-
-
2642677624
-
Improving protein therapeutics with sustained-release formulations
-
Putney, S.D. & Burke, P.A. Improving protein therapeutics with sustained-release formulations. Nat. Biotechnol. 16, 153-157 (1998).
-
(1998)
Nat. Biotechnol.
, vol.16
, pp. 153-157
-
-
Putney, S.D.1
Burke, P.A.2
-
13
-
-
0028559724
-
Solid-phase aggregation of proteins under pharmaceutically relevant conditions
-
Costantino, H.R., Langer, R. & Klibanov, A.M. Solid-phase aggregation of proteins under pharmaceutically relevant conditions. J. Pharm. Sci. 83, 1662-1669 (1994).
-
(1994)
J. Pharm. Sci.
, vol.83
, pp. 1662-1669
-
-
Costantino, H.R.1
Langer, R.2
Klibanov, A.M.3
-
15
-
-
0033043628
-
The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins
-
Shenderova, A., Burke, T. & Schwendeman, S.P. The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins. Pharm. Res. 16, 241-248 (1999).
-
(1999)
Pharm. Res.
, vol.16
, pp. 241-248
-
-
Shenderova, A.1
Burke, T.2
Schwendeman, S.P.3
-
16
-
-
0033026897
-
pH and osmotic pressure inside biodegradable microspheres during erosion
-
Brunner, A., Mäder, K. & Göpferich, A. pH and osmotic pressure inside biodegradable microspheres during erosion. Pharm. Res. 16, 847-853 (1999).
-
(1999)
Pharm. Res.
, vol.16
, pp. 847-853
-
-
Brunner, A.1
Mäder, K.2
Göpferich, A.3
-
17
-
-
0031751359
-
Monitoring microviscosity and microacidity of the albumin microenvironment inside degrading microparticles from poly(lactide-co-glycolide) (PLG) or ABA-triblock polymers containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethyleneoxide) B blocks
-
Mader, K., Bittner, B., Li, Y., Wohlauf, W. & Kissel, T. Monitoring microviscosity and microacidity of the albumin microenvironment inside degrading microparticles from poly(lactide-co-glycolide) (PLG) or ABA-triblock polymers containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethyleneoxide) B blocks. Pharm. Res. 15, 787-793 (1998).
-
(1998)
Pharm. Res.
, vol.15
, pp. 787-793
-
-
Mader, K.1
Bittner, B.2
Li, Y.3
Wohlauf, W.4
Kissel, T.5
-
18
-
-
0031869696
-
Visualization of pH in degrading polymer microspheres
-
Fu, K., Pack, D.W., Laverdiere, A., Son, S. & Langer, R. Visualization of pH in degrading polymer microspheres. Proceedings 25th International Symposium on Controlled Resealse of Bioactive Materials 25, 150-151 (1998).
-
(1998)
Proceedings 25th International Symposium on Controlled Resealse of Bioactive Materials
, vol.25
, pp. 150-151
-
-
Fu, K.1
Pack, D.W.2
Laverdiere, A.3
Son, S.4
Langer, R.5
-
19
-
-
0041718431
-
Non-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopy
-
Mader, K.,Gallez, B., Liu, K.J. & Swartz, H.M. Non-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopy. Biomaterials 17, 457-461 (1996).
-
(1996)
Biomaterials
, vol.17
, pp. 457-461
-
-
Mader, K.1
Gallez, B.2
Liu, K.J.3
Swartz, H.M.4
-
21
-
-
0024806396
-
Stability of protein pharmaceuticals
-
Manning, M.C., Patella, L & Borchardt, RT. Stability of protein pharmaceuticals. Pharm. Res. 6, 903-917 (1989).
-
(1989)
Pharm. Res.
, vol.6
, pp. 903-917
-
-
Manning, M.C.1
Patella, L.2
Borchardt, R.T.3
-
22
-
-
0025647106
-
Development of poly(ortho esters): A historical overview
-
Heller, J. Development of poly(ortho esters): a historical overview. Biomaterials 11, 659-665 (1990).
-
(1990)
Biomaterials
, vol.11
, pp. 659-665
-
-
Heller, J.1
-
23
-
-
0025510186
-
Structure-property relationships in the case of the degradation of massive poly(a-hydroxy acids) in aqueous media. Part 3. Influence of the morphology of poly(L-lactic acid)
-
Li, S.M., Garreau, H. & Vert, M. Structure-property relationships in the case of the degradation of massive poly(a-hydroxy acids) in aqueous media. Part 3. Influence of the morphology of poly(L-lactic acid). J. Mater. Sci. 1, 123-130 (1990).
-
(1990)
J. Mater. Sci.
, vol.1
, pp. 123-130
-
-
Li, S.M.1
Garreau, H.2
Vert, M.3
-
24
-
-
0025167027
-
Biodegradable polymer systems for the sustained release of polypeptides
-
Hutchinson, F.G. & Furr, B.J.A. Biodegradable polymer systems for the sustained release of polypeptides. J. Controlled Release13, 279-294 (1990).
-
(1990)
J. Controlled Release
, vol.13
, pp. 279-294
-
-
Hutchinson, F.G.1
Furr, B.J.A.2
-
25
-
-
0003825836
-
-
eds Pearlman, R. & Wang, Y.J. Plenum Press, New York
-
Wang, Y.J. et al. in Formulation, characterization, and stability of protein drugs (eds Pearlman, R. & Wang, Y.J.) 141-180 (Plenum Press, New York; 1996).
-
(1996)
Formulation, Characterization, and Stability of Protein Drugs
, pp. 141-180
-
-
Wang, Y.J.1
-
26
-
-
0027459523
-
Perivascular and intravenous administration of basic fibroblast growth factor: Vascular and solid organ deposition
-
Edelman, E.R., Nugent, M.A. & Karnovsky, M.J. Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition. Proc. Natl. Acad. Sci. USA 90, 1513-1517 (1993).
-
(1993)
Proc. Natl. Acad. Sci. USA
, vol.90
, pp. 1513-1517
-
-
Edelman, E.R.1
Nugent, M.A.2
Karnovsky, M.J.3
-
27
-
-
0028306824
-
Incorporation of basic fibroblast growth factor into methylpyrrolidinone chitosan fleeces and determination of the in vitro release characteristics
-
Berscht, P.C., Nies, B., Liebendorfer, A. & Kreuter, J. Incorporation of basic fibroblast growth factor into methylpyrrolidinone chitosan fleeces and determination of the in vitro release characteristics. Biomaterials 15, 593-600 (1994).
-
(1994)
Biomaterials
, vol.15
, pp. 593-600
-
-
Berscht, P.C.1
Nies, B.2
Liebendorfer, A.3
Kreuter, J.4
-
28
-
-
0028325205
-
Aluminium beta-cyclodextrin sulphate a stabilizer and sustained-release carrier for basic fibroblast growth factor
-
Fukunaga, K. et al. Aluminium beta-cyclodextrin sulphate a stabilizer and sustained-release carrier for basic fibroblast growth factor. J. Pharm. Pharmacol. 46, 168-171 (1994).
-
(1994)
J. Pharm. Pharmacol.
, vol.46
, pp. 168-171
-
-
Fukunaga, K.1
-
29
-
-
0025735802
-
Controlled and modulated release of basic fibroblast growth factor
-
Edelman, E.R., Mathiowitz, E., Langer, R. & Klagsbrun, M. Controlled and modulated release of basic fibroblast growth factor. Biomaterials 12, 619-626 (1991).
-
(1991)
Biomaterials
, vol.12
, pp. 619-626
-
-
Edelman, E.R.1
Mathiowitz, E.2
Langer, R.3
Klagsbrun, M.4
-
30
-
-
0031172982
-
In vitro assessment of the biological activity of basic fibroblast growth factor released from various polymers and biomatrices
-
Davies, M.J. et al. In vitro assessment of the biological activity of basic fibroblast growth factor released from various polymers and biomatrices. Journal of Biomaterial Applications 12, 31-56 (1997).
-
(1997)
Journal of Biomaterial Applications
, vol.12
, pp. 31-56
-
-
Davies, M.J.1
-
31
-
-
0025216220
-
Recombinant human bone morphogenetic protein induces bone formation
-
Wang, E.A. et al. Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. USA 87, 2220-2224 (1990).
-
(1990)
Proc. Natl. Acad. Sci. USA
, vol.87
, pp. 2220-2224
-
-
Wang, E.A.1
-
32
-
-
0031683897
-
Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model
-
Welch, R.D. et al. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model. J. Bone Miner. Res. 13, 1483-1490 (1998).
-
(1998)
J. Bone Miner. Res.
, vol.13
, pp. 1483-1490
-
-
Welch, R.D.1
-
33
-
-
0029891982
-
Maxillary alveolar cleft repair in dogs using recombinant human bone morphogenetic protein-2 and a polymer carrier
-
Mayer, M., Hollinger, J., Ron, E. & Wozney, J. Maxillary alveolar cleft repair in dogs using recombinant human bone morphogenetic protein-2 and a polymer carrier. Plast. Reconstr. Surg. 98, 247-259 (1996).
-
(1996)
Plast. Reconstr. Surg.
, vol.98
, pp. 247-259
-
-
Mayer, M.1
Hollinger, J.2
Ron, E.3
Wozney, J.4
-
34
-
-
0027423718
-
Biotechnology and bone graft substitutes
-
Kenley, R.A. et al. Biotechnology and bone graft substitutes Pharm. Res. 10, 1393-1401 (1993).
-
(1993)
Pharm. Res.
, vol.10
, pp. 1393-1401
-
-
Kenley, R.A.1
-
35
-
-
0022477372
-
Heparin protects basic and acidic FGF from inactivation
-
Gospodarowicz, D. & Cheng, J. Heparin protects basic and acidic FGF from inactivation. J. Cell. Physiol. 128, 475-484 (1986).
-
(1986)
J. Cell. Physiol.
, vol.128
, pp. 475-484
-
-
Gospodarowicz, D.1
Cheng, J.2
-
36
-
-
0024579448
-
Interaction of heparin with human basic fibroblast growth factor: Protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan
-
Sommer, A. & Rifkin, D.B. Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan. J. Cell. Physiol. 138, 215-220 (1989).
-
(1989)
J. Cell. Physiol.
, vol.138
, pp. 215-220
-
-
Sommer, A.1
Rifkin, D.B.2
-
37
-
-
0022950668
-
Purification and assay of intact human basic fibroblast growth factor using heparin-sepharose chromatography
-
Sullivan, R. & Klagsbrun, M. Purification and assay of intact human basic fibroblast growth factor using heparin-sepharose chromatography. J. Tiss. Culture Methods 10, 125-132 (1986).
-
(1986)
J. Tiss. Culture Methods
, vol.10
, pp. 125-132
-
-
Sullivan, R.1
Klagsbrun, M.2
-
38
-
-
0030953526
-
Adsorption determines in-vitro protein release rate from biodegradable microspheres: Quantitative analysis of surface area during degradation
-
Crotts, G., Sah, H. & Park, T.G. Adsorption determines in-vitro protein release rate from biodegradable microspheres: quantitative analysis of surface area during degradation. J. Controlled Release. 47, 101-111 (1997).
-
(1997)
J. Controlled Release
, vol.47
, pp. 101-111
-
-
Crotts, G.1
Sah, H.2
Park, T.G.3
-
39
-
-
0027253328
-
Controlled release of albumin from biodegradable poly(DL-lactide) cylinders
-
Zhang, X., Wyss, U.P, Amsden, B. & Goosen, M.F.A. Controlled release of albumin from biodegradable poly(DL-lactide) cylinders. J. Controlled Release 25, 61-69 (1993).
-
(1993)
J. Controlled Release
, vol.25
, pp. 61-69
-
-
Zhang, X.1
Wyss, U.P.2
Amsden, B.3
Goosen, M.F.A.4
-
40
-
-
0025731293
-
Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres
-
Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, LH. & Langer, R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res. 8, 713-720 (1991).
-
(1991)
Pharm. Res.
, vol.8
, pp. 713-720
-
-
Cohen, S.1
Yoshioka, T.2
Lucarelli, M.3
Hwang, L.H.4
Langer, R.5
-
41
-
-
0028789630
-
Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation
-
Schwendeman, S.P. et al. Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation. Proc. Natl. Acad. Sci. USA 92, 11234-11238 (1995).
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 11234-11238
-
-
Schwendeman, S.P.1
-
42
-
-
0026071674
-
Moisture-induced aggregation of lyophilized proteins in the solid state
-
Liu, W.R., Langer, R. & Klibanov, A.M. Moisture-induced aggregation of lyophilized proteins in the solid state. Biotechnol. Bioeng. 37, 177-184 (1991).
-
(1991)
Biotechnol. Bioeng.
, vol.37
, pp. 177-184
-
-
Liu, W.R.1
Langer, R.2
Klibanov, A.M.3
-
43
-
-
0030772855
-
Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles
-
Shenderova, A., Burke, T.G. & Schwendeman, S.P. Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles. Pharm. Res. 14, 1406-1413 (1997).
-
(1997)
Pharm. Res.
, vol.14
, pp. 1406-1413
-
-
Shenderova, A.1
Burke, T.G.2
Schwendeman, S.P.3
-
44
-
-
0026081021
-
A sensitive enzyme immunoassay for human basic fibroblast growth factor
-
Watanabe, H. et al. A sensitive enzyme immunoassay for human basic fibroblast growth factor. Biochem. Biophys. Res. Commun. 175, 229-235 (1991).
-
(1991)
Biochem. Biophys. Res. Commun.
, vol.175
, pp. 229-235
-
-
Watanabe, H.1
-
45
-
-
0028609969
-
Detection of elevated basic fibroblast growth factor during early hours of in vitro angiogenesis using a fast ELISA immunoassay
-
Gabra, N., Khiat, A. & Calabresi, P. Detection of elevated basic fibroblast growth factor during early hours of in vitro angiogenesis using a fast ELISA immunoassay. Biochem. Biophys. Res. Commun. 205, 1423-1430 (1994).
-
(1994)
Biochem. Biophys. Res. Commun.
, vol.205
, pp. 1423-1430
-
-
Gabra, N.1
Khiat, A.2
Calabresi, P.3
|